These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30873263)
21. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice. Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157 [TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice. Hosseini ZS; Amani J; Baghbani Arani F; Nazarian S; Motamedi MJ; Shafighian F Clin Exp Vaccine Res; 2018 Jan; 7(1):51-60. PubMed ID: 29399580 [TBL] [Abstract][Full Text] [Related]
23. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2. Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068 [TBL] [Abstract][Full Text] [Related]
24. Intranasal immunisation with Stx2B-Tir-Stx1B-Zot protein leads to decreased shedding in goats after challenge with Escherichia coli O157:H7. Zhang XH; He KW; Zhao PD; Ye Q; Luan XT; Yu ZY; Wen LB; Ni YX; Li B; Wang XM; Guo RL; Zhou JM; Mao AH Vet Rec; 2012 Feb; 170(7):178. PubMed ID: 22186381 [TBL] [Abstract][Full Text] [Related]
25. Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles. Choi KS; Kim SH; Kim ED; Lee SH; Han SJ; Yoon S; Chang KT; Seo KY PLoS One; 2014; 9(7):e100229. PubMed ID: 25032703 [TBL] [Abstract][Full Text] [Related]
33. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice. Babiuk S; Asper DJ; Rogan D; Mutwiri GK; Potter AA Microb Pathog; 2008 Jul; 45(1):7-11. PubMed ID: 18487034 [TBL] [Abstract][Full Text] [Related]
34. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein]. Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161 [TBL] [Abstract][Full Text] [Related]
35. Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins. Fan HY; Wang L; Luo J; Long BG Mol Biol Rep; 2012 Feb; 39(2):989-97. PubMed ID: 21567195 [TBL] [Abstract][Full Text] [Related]
36. In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli. Novinrooz A; Zahraei Salehi T; Firouzi R; Arabshahi S; Derakhshandeh A PLoS One; 2017; 12(3):e0173761. PubMed ID: 28296951 [TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of chitosan nanoparticles containing CtxB antigen against Vibrio cholera. Tabrizi NM; Amani J; Ebrahimzadeh M; Nazarian S; Kazemi R; Almasian P Microb Pathog; 2018 Nov; 124():170-177. PubMed ID: 30138759 [TBL] [Abstract][Full Text] [Related]
39. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2. Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720 [TBL] [Abstract][Full Text] [Related]
40. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization. Tapia D; Ross BN; Kalita A; Kalita M; Hatcher CL; Muruato LA; Torres AG Front Cell Infect Microbiol; 2016; 6():94. PubMed ID: 27625996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]